ELV - Elevance Health Inc.

ELV

$393.19 +0.44 (+0.11%) Last updated: May 31, 2026 08:34

52-Week Range

$393.19

$273.71 $393.19 $408.00

Fundamentals Overview

Elevance Health Inc. is near the high of its 52-week range with moderate valuation, trading relatively flat today.

Valuation moderate

P/E 16.5 P/B 1.97 P/S 0.43

Intrinsic value (DCF)

+197.2% upside vs price

Profitability

Net margin 2.6%

Risk (Beta)

0.67 — lower vol

Earnings & growth

EPS $23.79 Rev +0.9% Profit +222.5% vs prior qtr

BullzEye Analysis

Our composite tilts Buy on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell

Buy

Buy — 69% confidence Risk: Lower Volatility — Beta 0.67. Diversify and only invest what you can afford to lose.

Supporting (Buy):

DCF +197.2% upside vs price · 3M vs S&P 500: +9.8% · 3M vs Healthcare sector: +24.3%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap

$85.39B

P/E (TTM)

16.53

EPS (TTM)

$23.79

Dividend Yield

1.74%

52-Week Range

$273.71 - $408.00

Volume vs Avg

N/A

Beta

0.67

About

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and i...

Sector: Healthcare

Headquarters: US

Employees: 104,200

IPO Date: Oct 2001

Website: www.elevancehealth.com

Beta: 0.67 (Less volatile than market)

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $1,168.75; current price is $393.19. That’s a +197.2% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric	Value
Valuation
P/E (TTM)	16.53
DCF value (model)	$1,168.75 (197.2% upside)
PEG (TTM)	N/A
P/B (TTM)	1.97
P/S (TTM)	0.43
P/FCF (TTM)	13.24
Liquidity & enterprise
Current Ratio (TTM)	1.48
Quick Ratio (TTM)	1.48
Cash Ratio (TTM)	0.21
Profitability
ROE (TTM)	N/A
ROA (TTM)	N/A
Revenue growth (YoY)	N/A
Net margin (TTM)	2.62%
Gross margin (TTM)	23.16%
Operating margin (TTM)	3.81%
Debt to equity (TTM)	N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for ELV.

Price Target Consensus

Current $393.19

Median $404.00

Consensus $406.31

Low consensus $331.00

High consensus $498.00

Stock Grades (Institutions)

No stock grades available for this symbol.